Oric Pharmaceuticals (ORIC)Director bought ~$250K

~$250K

Approx. value · 27K sh @ $9.39

27K

Holds after · shares reported

Traded

Jun 20, 2025

Filed

Jun 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 6, 2025InsiderCFO sold ~$26K of ORIC shares in the open market
2. Jun 9, 2025InsiderCFO sold ~$3K of ORIC shares in the open market
3. Jun 10, 2025InsiderCFO sold ~$3.2K of ORIC shares in the open market
4. Jun 11, 2025Insider · 1 personInsiders: 2 sales (~$30K)
5. Jun 12, 2025InsiderCFO sold ~$3K of ORIC shares in the open market
6. Jun 20, 2025 · this disclosureInsiderDirector purchased ~$250K of ORIC shares in the open market

What came next

1. Jun 23, 2025Insider · 2 peopleInsiders: 1 purchase (~$13K), 2 sales (~$10K)
2. Jun 24, 2025InsiderCFO sold ~$341K of ORIC shares in the open market
3. Jul 1, 2025InsiderCFO sold ~$201K of ORIC shares in the open market
4. Sep 22, 2025Insider · Their largest sale since 2021CEO sold ~$1.35M of ORIC shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Oric Pharmaceuticals

For Oric Pharmaceuticals, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ORIC page.

Other recent filings by Angie You, Director

• SEC Form 4 at Oric Pharmaceuticals (ORIC)Jun 24, 2025

The full history of Angie You, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Oric Pharmaceuticals

• SEC Form 4Oct 2, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 29, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 4Sep 25, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its ORIC page.